Teenager’s sickle cell reversed with world-first therapy – BBC News
Next Big Future |
Teenager’s sickle cell reversed with world-first therapy
BBC News A French teenager’s sickle cell disease has been reversed using a pioneering treatment to change his DNA. The world-first procedure at Necker Children’s Hospital in Paris offers hope to millions of people with the blood disorder. Scientists altered the … Gene therapy product shows early promise in sickle cell diseaseHealio Gene Therapy cures sickle cell in teenage boyNext Big Future Gene therapy relieves sickle cell in world firstNews24 Gizmodo –Doctors Lounge all 10 news articles » |
RFI |
In world-first breakthrough, French doctors use gene therapy to treat rare blood disease
RFI For the first time, gene therapy has been used to treat a boy with sickle cell disease in Paris. The medical treatment was developed and administered by a research team from Paris’s public hospital system, Assistance Publique-Hôpitaux de Paris (AP-HP). |
|
United States: Walking The Tight Rope: A Lesson From The CRISPR-Cas9 Dispute
Mondaq News Alerts (registration) In determining ownership of the CRISPR-Cas9 technology (a tool that enables gene editing through the alteration of DNA sequences), which may be considered the most significant and important biotech breakthrough of this generation, the PTO issued a win … Round one of the the US CRISPR patent battle is over – but what does the PTABS’s no interference-in-fact decision …JD Supra (press release) |
EurekAlert (press release) |
Want more crop variety? Researchers propose using CRISPR to accelerate plant domestication
EurekAlert (press release) But with CRISPR technology, we don’t have to wait for nature to help us domesticate plants, argue researchers at the University of Copenhagen. In a Review published March 2 in Trends in Plant Science, they describe how gene editing could make, … |
Phys.Org |
Want more crop variety? Researchers propose using CRISPR to accelerate plant domestication
Phys.Org But with CRISPR technology, we don’t have to wait for nature to help us domesticate plants, argue researchers at the University of Copenhagen. In a Review published March 2 in Trends in Plant Science, they describe how gene editing could make, … |
Endpoints News |
Bluebird’s star gene therapy patient still doing well after 15 months-plus; Takeda, Arix partner on biotech startups
Endpoints News Patient 1204 in bluebird’s program for LentiGlobin gene therapy program has had more than 15 months of followup, and his physicians say that the teenager has been free of the painful symptoms of sickle cell disease, able to lead a normal life and stop … |